Article Information
History
- July 6, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jiasheng Shao1,*,
- Rong Fan2,*,
- Tiejun Zhang3,*,
- Catherine Lee4,
- Xuyuan Huang5,
- Fei Wang6,
- Haiying Liang7,
- Ye Jin7,
- Ying Jiang7,
- Yanhua Gu8,
- Jianrong Hu7,# and
- Gang Huang9,#
- 1Department of Infectious Diseases and Immunology, Jiading District Central Hospital, Shanghai University of Medicine and Health Sciences, Shanghai 201899, China
- 2Genomics, Center for Molecular and Cellular Bioengineering, Biotechnology Center, Technische Universität Dresden 01307, Germany
- 3Department of Epidemiology, School of Public Health, Fudan University, Shanghai 200032, China
- 4College of Public Health, University of Georgia, Athens, GA 30602, USA
- 5Department of Urology, Renji Hospital, Shanghai Jiaotong University, Shanghai 200127, China
- 6Department of Intensive Care Unit, Jiading District Central Hospital, Shanghai 201899, China
- 7Department of Respiratory Medicine, Jiading District Central Hospital, Shanghai 201899, China
- 8Department of Nursing, Jiading District Central Hospital, Shanghai 201899, China
- 9Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China
- ↵#Corresponding Authors:
Shanghai Key Laboratory of Molecular Imaging, Shanghai University of Medicine and Health Sciences, Shanghai 201318, China, E-mail address: huanggang{at}sumhs.edu.cn (G. Huang), Tel: 86-021-65881330, Department of Respiratory Medicine, Jiading District Central Hospital, Shanghai 201899, China E-mail address: hujianrong{at}jdhospital.com (J. Hu), Tel: 86-021-67073583
↵* These authors contributed equally to this work.
Posted July 06, 2022.
Clinical advancement of patients infected with SARS-CoV-2 Omicron variant in Shanghai, China
